Funding
This study was funded by CStone Pharmaceuticals, Aus Pty., Ltd., Sydney, Australia, and CStone Pharmaceuticals (Suzhou) Co., Ltd., Suzhou, China. The study sponsors collected, analyzed, and interpreted the data in conjunction with the authors, who had access to all the data. Open Access funding enabled and organized by CAUL and its Member Institutions.